Clinical Trials Browser

Phase 2 × Interventional × Microscopy × Clear all

NCT01118351 2019-05-01

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Phase 2 Terminated

19 enrolled 11 charts

Urinary Bladder Neoplasms